Sofosbuvir/velpatasvir/voxilaprevir

http://dbpedia.org/resource/Sofosbuvir/velpatasvir/voxilaprevir an entity of type: Thing

Sofosbuvir/velpatasvir/voxilaprevir (nombre comercial Vosevi) es un medicamento combinado para el tratamiento de la hepatitis C. Combina tres medicamentos que actúan cada uno mediante un mecanismo de acción diferente contra el virus de la hepatitis C: sofosbuvir, velpatasvir y voxilaprevir. Vosevi fue aprobado por la Administración de Alimentos y Medicamentos en julio de 2017​ y recibió una opinión positiva del Comité Europeo de Medicamentos para Uso Humano en junio de 2017.​ Vosevi es vendido por Gilead Sciences. rdf:langString
Sofosbuvir/velpatasvir/voxilaprevir, sold under the brand name Vosevi, is a fixed-dose combination medication for the treatment of hepatitis C. It combines three drugs that each act by a different mechanism of action against the hepatitis C virus: sofosbuvir, velpatasvir, and voxilaprevir. Vosevi was approved for medical use in the United States and in the European Union in July 2017. Vosevi is sold by Gilead Sciences. rdf:langString
rdf:langString Sofosbuvir/velpatasvir/voxilaprevir
rdf:langString Sofosbuvir/velpatasvir/voxilaprevir
xsd:integer 56145468
xsd:integer 1038356930
rdf:langString AP56
rdf:langString J05
xsd:integer 111
xsd:integer 1190307 1377049 1535212
rdf:langString NS3/4A protease inhibitor
rdf:langString NS5A inhibitor
rdf:langString NS5B RNA polymerase inhibitor
rdf:langString Sofosbuvir
rdf:langString Velpatasvir
rdf:langString Voxilaprevir
xsd:integer 5
xsd:integer 135
rdf:langString D10900
rdf:langString Rx-only
rdf:langString a617037
xsd:integer 17
xsd:integer 26
xsd:integer 1
rdf:langString N
xsd:integer 129011857
xsd:integer 1
rdf:langString CCC1C2CNCCCC.CC1CCCC2=NC3=CC=CC4=CC5=COCC6=C5C=CCC7=CN=CC8CCCOC.CCOCCNPOC3=CC=CC=C3
xsd:integer 1
rdf:langString FMWRYUBVSONSCK-ZYTFCPLVSA-N
rdf:langString Vosevi
rdf:langString combo
xsd:integer 570
rdf:langString KCU0C7RS7Z
rdf:langString WJ6CA3ZU8B
rdf:langString Sofosbuvir/velpatasvir/voxilaprevir (nombre comercial Vosevi) es un medicamento combinado para el tratamiento de la hepatitis C. Combina tres medicamentos que actúan cada uno mediante un mecanismo de acción diferente contra el virus de la hepatitis C: sofosbuvir, velpatasvir y voxilaprevir. Vosevi fue aprobado por la Administración de Alimentos y Medicamentos en julio de 2017​ y recibió una opinión positiva del Comité Europeo de Medicamentos para Uso Humano en junio de 2017.​ Vosevi es vendido por Gilead Sciences.
rdf:langString Sofosbuvir/velpatasvir/voxilaprevir, sold under the brand name Vosevi, is a fixed-dose combination medication for the treatment of hepatitis C. It combines three drugs that each act by a different mechanism of action against the hepatitis C virus: sofosbuvir, velpatasvir, and voxilaprevir. Vosevi was approved for medical use in the United States and in the European Union in July 2017. Vosevi is sold by Gilead Sciences.
rdf:langString Vosevi
rdf:langString S4
rdf:langString Rx-only
rdf:langString B1
xsd:nonNegativeInteger 6846
rdf:langString Vosevi
xsd:string 1190307-88-0
xsd:string 1377049-84-7
xsd:string KCU0C7RS7Z
xsd:string WJ6CA3ZU8B
xsd:string D10900
xsd:string a617037
xsd:string 129011857
owl:Thing
<http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject>
dbpedia-owl:ChemicalSubstance
<http://www.wikidata.org/entity/Q8386>
dbpedia-owl:CombinationDrug
dbpedia-owl:Drug
<http://dbpedia.org/resource/Category:NS5B_(polymerase)_inhibitors>
<http://dbpedia.org/resource/Category:NS5A_inhibitors>
<http://dbpedia.org/resource/Category:NS3/4A_protease_inhibitors>
<http://dbpedia.org/resource/Category:Combination_drugs>
<http://dbpedia.org/resource/Category:NS5B_(polymerase)_inhibitors>
<http://dbpedia.org/resource/Category:NS5A_inhibitors>
<http://dbpedia.org/resource/Velpatasvir>
<http://dbpedia.org/resource/Oral_administration>
<http://dbpedia.org/resource/Gilead_Sciences>
<http://dbpedia.org/resource/Voxilaprevir>
<http://dbpedia.org/resource/Hepatitis_C>
<http://dbpedia.org/resource/Category:NS3/4A_protease_inhibitors>
<http://dbpedia.org/resource/Category:Combination_drugs>
<http://dbpedia.org/resource/Hepatitis_C_virus>
<http://dbpedia.org/resource/Sofosbuvir>
<http://dbpedia.org/resource/Mechanism_of_action>
<http://dbpedia.org/resource/Fixed-dose_combination>
<https://druginfo.nlm.nih.gov/drugportal/name/sofosbuvir%20mixture%20with%20velpatasvir%20and%20voxilaprevir>
<http://www.wikidata.org/entity/Q48564241>
<http://es.dbpedia.org/resource/Sofosbuvir/velpatasvir/voxilaprevir>
<http://vi.dbpedia.org/resource/Sofosbuvir/velpatasvir/voxilaprevir>
<https://global.dbpedia.org/id/4WFs6>
<http://dbpedia.org/resource/Template:Cite_web>
<http://dbpedia.org/resource/Template:Infobox_drug>
<http://dbpedia.org/resource/Template:Portal_bar>
<http://dbpedia.org/resource/Template:Reflist>
<http://dbpedia.org/resource/Template:Use_dmy_dates>
<http://dbpedia.org/resource/Template:Cascite>
<http://dbpedia.org/resource/Template:Fdacite>
<http://dbpedia.org/resource/Template:Drugs.com>
<http://dbpedia.org/resource/Template:RNA_antivirals>
<http://dbpedia.org/resource/Template:Antiinfective-drug-stub>
<http://dbpedia.org/resource/Oral_administration>
<http://en.wikipedia.org/wiki/Sofosbuvir/velpatasvir/voxilaprevir?oldid=1038356930&ns=0>
<http://en.wikipedia.org/wiki/Sofosbuvir/velpatasvir/voxilaprevir>

data from the linked data cloud